Re: Maybe we are getting very close to M&A-- ( dys1)

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

aimgator

Rank: Treasurer [?]

Points: 2347 [?]

Votes: 53 Score: 2.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Maybe we are getting very close to M&A-- ( dys1)

in response to

Re: Maybe we are getting very close to M&A-- ( dys1)

dys1

posted on Jun 17, 2008 10:48AM

"If you M&A IP, then you're back to points #1 & #2, particulary since PTSC indicated they would use TPL for further IP licensing income"

- Keep in mind that in the new IP.. the negoitations may be very different as TPL would not be a 50% owner of the IP that PTSC is selling. TPL would just be an authorized "seller" of the product. Of course they would recieve their % but i doubt its anywhere near 50%........ PTSC also would have control as to the prices, etc.

The MMP issue is different because TPL is a co-owner and we are going back to tell customers that are infringing.

PTSC can control some events... by working on that M&A or additional revenue stream. Since they havent -SP decline as the only visible revenues are the ones that are "uncertain or in doubt"...